Cargando…
Auranofin: Repurposing an Old Drug for a Golden New Age
Drug discovery, development and registration is an expensive and time-consuming process associated with a high failure rate [Pessetto et al. (Mol Cancer Ther 12:1299–1309, 2013), Woodcock and Woosley (Annu Rev Med 59:1–12, 2008)]. Drug ‘repurposing’ is the identification of new therapeutic purposes...
Autores principales: | Roder, Christine, Thomson, Melanie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359176/ https://www.ncbi.nlm.nih.gov/pubmed/25698589 http://dx.doi.org/10.1007/s40268-015-0083-y |
Ejemplares similares
-
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
por: Sisignano, Marco, et al.
Publicado: (2022) -
The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
por: Haider, Malik Salman, et al.
Publicado: (2021) -
Will Auranofin Become a Golden New Treatment Against COVID-19?
por: Sonzogni-Desautels, Karine, et al.
Publicado: (2021) -
Human Monkeypox: Old virus with new Epidemiological and Transmission Trends
por: Meo, Sultan Ayoub
Publicado: (2022) -
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018)